Xatral (alfuzosin) tablets

Xatral is a prescription medication primarily used to treat symptoms associated with benign prostatic hyperplasia (BPH). The active ingredient is alfuzosin hydrochloride, which belongs to a class of drugs known as alpha-blockers. This medication works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.

The brand was originally developed by Sanofi, a leading global pharmaceutical healthcare company. While the brand has its roots in France, the manufacturing of Xatral and its generic versions occurs in multiple locations across Europe and North America to serve international markets. Today, Sanofi remains the ultimate owner and distributor of the product, maintaining its position as one of the world's largest pharmaceutical entities with a focus on human health.